MOBERG DERMA PROFITABLE ALREADY 2012

MOBERG DERMA PROFITABLE ALREADY 2012

The Board of Moberg Derma AB (OMX: MOB) assessed that the company has the
potential to show profitability already full-year 2012 based on continued
positive development and revenue growth. Moberg Derma therefore updates its
financial goals. Its short-term goal of operative profit and cash flow for the
full-year 2013 is omitted, since it is assessed that profitability can be
achieved already 2012. The long term (3-5 years) financial goal remains - to
achieve an operating margin before depreciation and amortization (operating
profit as a percentage of sales) of 25% with continued strong growth.

”Strong international sales growth for Nalox™/Emtrix® in combination with a
significantly improved gross margin gives us opportunities to achieve
profitability as early as 2012”, say Peter Wolpert, CEO and founder of Moberg
Derma.
About this information
Moberg Derma discloses the information provided herein pursuant to the
Securities Markets Act and/or the Financial Instruments Trading Act. The
information was submitted for publication at 08:00 am (CET) on March 13th, 2012.

For further information, please contact:
Peter Wolpert, President and CEO
Telephone: +46 8 522 307 00
Mobile: +46 735 71 35
E-mail: peter.wolpert@mobergderma.se

Magnus Persson, IR
Mobile: +46 73-355 26 01
E-mail: magnus.persson@mobergderma.se